Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences Point-of-Care Diagnostics & Global Health 2018

Point-of-Care Diagnostics & Global Health 2018

Date: Monday, 1 October 2018 - Wednesday, 3 October 2018
Location: Coronado Island, California


Moderator

Leanna Levine

Leanna Levine
President & CEO, ALine, Inc.

Keynote Speakers

John McDevitt

John McDevitt
Chair, Department Biomaterials, New York University College of Dentistry Bioengineering Institute

Chwee Teck Lim

Chwee Teck Lim
NUS Society Chair Professor, Acting Director, Biomedical Institute for Global Health Research and Technology, National University of Singapore

Steve Soper

Steve Soper
Foundation Distinguished Professor, Director, Center of BioModular Multi-scale System for Precision Medicine, Adjunct Professor, Ulsan National Institute of Science & Technology, William H. Pryor Emeritus Chair of Chemistry, The University of Kansas

Bernhard Weigl

Bernhard Weigl
Director, Center for In-Vitro Diagnostics, Intellectual Ventures/Global Good-Bill Gates Venture Fund

Michael Heller

Michael Heller
Distinguished Scientist - Knight Cancer Institute at Oregon Health & Science University (OHSU), Center for Cancer Early Detection and Research (CEDAR); Professor, University of California-San Diego

Arben Merkoçi

Arben Merkoçi
ICREA Research Professor and Group Leader, Catalan Institute of Nanoscience and Nanotechnology Barcelona

Hsueh-Chia Chang

Hsueh-Chia Chang
Bayer Professor of Engineering, University of Notre Dame

Dino Di Carlo

Dino Di Carlo
Professor and Vice Chair of Bioengineering, University of California-Los Angeles

Martyn Boutelle

Martyn Boutelle
Professor of Biomedical Sensors Engineering, Vice Chair Department of Bioengineering, Imperial College London

John Brennan

John Brennan
Professor and Director, Biointerfaces Institute, McMaster University

Overview

Welcome to the SELECTBIO Point-of-Care Diagnostics and Global Health 2018.

This annual conference will discuss the expanding Point-of-Care Diagnostics and Global Health fields and bring in the Emerging Viral Diseases field providing the most up-to-date presentations from leaders in these fields and offer networking and engagement opportunities with delegates from around the world.

This conference will provide an overview of the point-of-care (POC) testing landscape, from novel technologies to regulatory approval.  Experts in these fields will share their views on point-of-care in the clinical setting. The aim of this meeting is to bring together life science researchers that work at the interface between biology and chemistry and technology development to discuss problems, highlight solutions and facilitating collaborations. Also, we frame the role of POC testing in the expanding Global Health field and highlight opportunities existing in many parts of the world.

This conference covers POC Detection, POC Diagnostics and POC-based Treatment Options as part of the Comprehensive Coverage of this Expanding Field. The POC testing field is expanding focused not only on infectious disease diagnostics (which represents approximately 80% of the marketplace) but also with cancer and cardiovascular disease focus. We address each of these segments in this conference.

Registered conference delegates have full access to the co-located parallel conferences:
  • Lab-on-a-Chip and Microfluidics: Emerging Themes, Technologies and Applications 2018
  • Lab-on-a-Chip and Microfluidics: Techologies and Commercialization 2018
  • Point-of-Care Diagnostics and Global Health 2018
  • Single Cell Analysis Summit 2018

Information and Local Registration Facilities for this Conference are also available in:

Japanese  |  Korean  |  Chinese (Simplified)  |  Chinese (Traditional)

Call for Posters

You can also present your research on a poster while attending the meeting. Submit an abstract for consideration now!

Poster Submission Deadline: 24 September 2018

Agenda Topics

  • Emerging Technologies and Emerging Companies Showcase
  • Global Health and Emerging Viral Diseases such as Ebola and Zika
  • Impact of Microfluidics/Lab-on-a-Chip Technologies for Point-of-Care (POC) Diagnostics Applications
    • Innovations in Technology Development
  • POC Diagnostics for Global Health: A Worldwide Perspective
    • Low-Cost POC Devices for Deployment Worldwide
    • POC Diagnostics in Resource-Limited Settings
  • POC Diagnostics in Infectious Disease Testing

Sponsorship and Exhibition Opportunities

Jeff Fan, Exhibition Manager
jeff@selectbioconferences.com
+1-510-857-4865

Confirmed Speakers to date

Amy Adelberger, Founder and CEO, Global Impact Advisors
Charles Daitch, CEO, Akonni Biosystems Inc.
James Downs, Business Development Manager, SCHOTT Nexterion
Paul Fleming, Program Director & Director of Site Operations, Ximedica
Jim Gallarda, Senior Program Officer, Bill & Melinda Gates Foundation
Luke Helm, Director of Business Development, Symbient Product Development
Hsuan-Yu Leu, Researcher, University of Utah
Robert Meagher, Principal Member of the Technical Staff, Sandia National Laboratories
Fred Mitchell, Engineering Development Manager, Wi, Inc.
Claudio Parolo, Research Fellow, University of California-Santa Barbara
Alexandra Perebikovsky, Researcher, University of California-Irvine
Chaminda Salgado, Cell & Gene Therapy Medicinal Process Delivery Leader, GlaxoSmithKline
Paul Yager, Professor, Department of Bioengineering, University of Washington


Corporate Sponsors Media Sponsors Official Journal Partner Networking
Drug Discovery WoMetaTagsrld U-Networks

Add to Calendar ▼2018-10-01 00:00:002018-10-03 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health 2018Point-of-Care Diagnostics and Global Health 2018 in Coronado Island, CaliforniaCoronado Island, CaliforniaSELECTBIOenquiries@selectbiosciences.com